Biomimetic nanodelivery system with simultaneous blood–brain barrier-crossing and neuroprotective abilities for anti-parkinsonian therapy
Collectively, the novel PD treatment approach developed in this study offers superior biosafety and treatment efficacy, highlighting its strong potential for clinical translation.
Authors
- Xianyong Yin (ORCID: https://orcid.org/0000-0001-6454-2384)
- Tongkai Chen (ORCID: https://orcid.org/0000-0002-4347-0155)
- Jinmei Qiu
- Chunye Zheng
- Guowang Cheng
- Chen Wang (ORCID: https://orcid.org/0000-0002-4296-6888)
- Jiaxin Wu (ORCID: https://orcid.org/0000-0002-2015-8206)
- Shuiqing Huang
Institutions
- Guangzhou University of Chinese Medicine (CN)
Publication Details
- Journal
- Chinese Medicine
- Published
- 2025-11-08
- DOI
- https://doi.org/10.1186/s13020-025-01239-2
- Citations
- 1
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.60